SEC Form 4 · accession 0001246360-15-003506
NxStage Medical, Inc. · NXTM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph E Turk Jr.
Officer — President
Period of report
Nov 3, 2015
Accepted (ET)
Nov 5, 2015 · 5:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001333170
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 3, 2015 | M | 826 | $9.96 | A | 108,789 | D | |
| Common Stock | Nov 3, 2015 | S | 826 | $18.00 | D | 107,963 | D | |
| Common Stock | Nov 4, 2015 | M | 4,000 | $9.96 | A | 111,963 | D | |
| Common Stock | Nov 4, 2015 | S | 4,000 | $19.96 | D | 107,963 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $9.96 | Nov 3, 2015 | M | 826 | D | Apr 3, 2010 | Mar 2, 2017 | Common Stock | 826 | 27,735 | D |
| Stock Option (Right to Buy) | $9.96 | Nov 4, 2015 | M | 4,000 | D | Apr 3, 2010 | Mar 2, 2017 | Common Stock | 4,000 | 23,735 | D |
Explanation of responses
- F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2015.